Skip to main content

Male Birth Control Treatment Could Focus on Sperm Proteins, Not Hormones


Credit: Stockxpert


A male form of "the pill" has stymied researchers for years, but now a new study finds that such male birth control may be possible by blocking a single protein in sperm cells.

In a mouse study, the researchers focused on a protein called calcineurin, which is found in the sperm-producing cells of the testes as well as other cells in the body.

The researchers genetically engineered mice so that they lacked a gene that makes part of the calcineurin protein but is activatedonly in sperm-producing cells. When these mice had sex, they were infertile, the researchers said. (This genetic engineering experiment was done as a proof of concept, to show that this gene affects sperm,)
In a separate experiment, the researchers treated the mice with two drugs that block calcineurin, called cyclosporine A and FK506. Both of these drugs are already used in patients who've had organ transplants to suppress the immune system and prevent the organ from being rejected by the body.

After about four to five days of treatment, the mice developed defects in their sperm and became infertile. But once the treatment was stopped, these defects went away, and the mice were fertile again within a week.

"Considering these results in mice, sperm calcineurin may be a target for reversible and rapidly acting human male contraceptives," the researchers, from Osaka University in Japan, wrote in the Oct. 1 issue of the journal Science Express. The researchers noted that human sperm also contain the calcineurin protein, and that part of the protein is specific to sperm. [Sexy Swimmers: 7 Facts About Sperm]

When the researchers tried to figure out why their genetically engineered mice were infertile, they found that the mice's sperm cells did not swim well and were not able to fertilize eggs. Further experiments found that themidpieces of these sperm didn't bend normally, which prevented the sperm from penetrating the membrane of an egg.

However, because the study was conducted in mice, it's not clear if the findings will translate to humans. In a small, previous study of nine men who took cyclosporine A after a kidney transplant, researchers found that three of the four men who attempted to have children were successful. But other studies in men have suggested that cyclosporine A does affect sperm movement.

Patricia Morris, director of biomedical research at the New York-based nonprofit research organization Population Council, said that calcineurin is an interesting target for a male contraceptive because it is not a hormone. Approaches to male contraception that target hormones can affect sex drive and thus are less desirable as contraceptives, said Morris, who was not involved in the new study in mice.

"We certainly need male contraceptives, and new designs that aren't hormone-based are really welcomed in terms of acceptability," Morris said.

In addition, targeting a protein that's found only in sperm would theoretically eliminate the possibility of side effects in other tissues, Morris told Live Science.

"The holy grail of any drug development is, you want it to be specific," Morris said. "And that's what makes [this] such an enticing, kind of exciting prospect."

Source: Live Science. | By: Rachael Rettner @RachaelRettner

Popular posts from this blog

Gene therapy treats all muscles in the body in muscular dystrophy dogs

Human clinical trials are next step..
Source: www.healthcare.uiowa.edu
Muscular dystrophy, which affects approximately 250,000 people in the U.S., occurs when damaged muscle tissue is replaced with fibrous, fatty or bony tissue and loses function. For years, scientists have searched for a way to successfully treat the most common form of the disease, Duchenne Muscular Dystrophy (DMD), which primarily affects boys. Now, a team of University of Missouri researchers have successfully treated dogs with DMD and say that human clinical trials are being planned in the next few years.

"This is the most common muscle disease in boys, and there is currently no effective therapy," said Dongsheng Duan, the study leader and the Margaret Proctor Mulligan Professor in Medical Research at the MU School of Medicine. "This discovery took our research team more than 10 years, but we believe we are on the cusp of having a treatment for the disease."

Patients with Duchenne muscular dyst…

Study adds to evidence that viruses are alive

The new findings appear in the journal Science Advances.

A new analysis supports the hypothesis that viruses are living entities that share a long evolutionary history with cells, researchers report. The study offers the first reliable method for tracing viral evolution back to a time when neither viruses nor cells existed in the forms recognized today, the researchers say.

Until now, viruses have been difficult to classify, said University of Illinois crop sciences and Carl R. Woese Institute for Genomic Biology professor Gustavo Caetano-Anoll├ęs, who led the new analysis with graduate student Arshan Nasir. In its latest report, the International Committee on the Taxonomy of Viruses recognized seven orders of viruses, based on their shapes and sizes, genetic structure and means of reproducing.

"Under this classification, viral families belonging to the same order have likely diverged from a common ancestral virus," the authors wrote. "However, only 26 (of 104) viral fam…

Schizophrenia symptoms linked to features of brain's anatomy?

Roger Harris/Photo Researchers, ISM/Phototake Using advanced brain imaging, researchers have matched certain behavioral symptoms of schizophrenia to features of the brain's anatomy. The findings, at Washington University School of Medicine in St. Louis, could be a step toward improving diagnosis and treatment of schizophrenia.
The study, available online in the journal NeuroImage, will appear in print Oct. 15.

"By looking at the brain's anatomy, we've shown there are distinct subgroups of patients with a schizophrenia diagnosis that correlates with symptoms," said senior investigator C. Robert Cloninger, MD, PhD, the Wallace Renard Professor of Psychiatry and a professor of genetics. "This gives us a new way of thinking about the disease. We know that not all patients with schizophrenia have the same issues, and this helps us understand why."

The researchers evaluated scans taken with magnetic resonance imaging (MRI) and a technique called diffusion ten…